Explicyte poster at ESMO IO Congress 2019 - by Explicyte Immuno-Oncology
ESMO 2016 - Elevar Therapeutics
Genialis ESMO 2022
Anaveon announces poster presentation at the 2023 European Society for Medical Oncology Annual Meeting - anaveon
PAK4 as a Potential Marker for Poor Response to Immunotherapy in Melanoma Patients - Biognosys
ESMO 2020 - Hallmarks of Cancer - Agendia
ESMO14 - Poster: STRIDE, a randomised, phase 2, open-label study of sipuleucel-T with concurrent versus sequential enzalutamide in metastatic castration-resistant prostate cancer (mCRPC)
Clarify Project participating at ESMO 21 - Clarify2020
INCA poster wins "Best Poster" at ESMO in Munich - NeuroEndocrine Cancer Australia
RS Research Announces Poster Presentation at the ESMO TAT 2023 Congress - RS Research
SAKK at the European Society for Medical Oncology (ESMO) Congress 2022
INCA presents poster at ESMO highlighting challenges in access to diagnosis and treatments for neuroendocrine cancer patients – UKI NETS
Imugene Limited - Our ESMO Asia 2019 poster presentation is now available for download http://ow.ly/NPEX50xhTvR | ASX: IMU #Oncology #BioTech #EndCancer #Immunotherapy #Cancer | Facebook
ESMO Breast Cancer 2023
SAKK presentations at the ESMO Congress 2021
ESMO Poster
ESMO Asia 2019 - Poster Display Session | European Society for Medical Oncology | Flickr
ESMO Asia 2019 - Poster Display Session | European Society for Medical Oncology | Flickr
PosterSessionOnline
VBI Vaccines Announces Biomarker Data from VBI-1901 Phase 1/2a Study in Recurrent GBM Presented at ESMO Virtual Congress 2020 - VBI Vaccines
ESMO22 Archives - anaveon
Poster at ESMO Asia 2019:: LC-SCRUM Presents Initial International Screening Results